KR970069987A - N,n- 디에틸- 8,8- 디프로필- 2- 아자스피로[4.5]데칸- 2- 프로판아민 이말레산염 - Google Patents

N,n- 디에틸- 8,8- 디프로필- 2- 아자스피로[4.5]데칸- 2- 프로판아민 이말레산염 Download PDF

Info

Publication number
KR970069987A
KR970069987A KR1019960028016A KR19960028016A KR970069987A KR 970069987 A KR970069987 A KR 970069987A KR 1019960028016 A KR1019960028016 A KR 1019960028016A KR 19960028016 A KR19960028016 A KR 19960028016A KR 970069987 A KR970069987 A KR 970069987A
Authority
KR
South Korea
Prior art keywords
dipropyl
decane
azaspiro
propanamine
maleate
Prior art date
Application number
KR1019960028016A
Other languages
English (en)
Other versions
KR100404832B1 (ko
Inventor
이. 데거 레이몬드
더블유. 그레디 캐롤린
Original Assignee
스티븐 베네티아너
스미스클라인 비참 코포레이션
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 스티븐 베네티아너, 스미스클라인 비참 코포레이션 filed Critical 스티븐 베네티아너
Publication of KR970069987A publication Critical patent/KR970069987A/ko
Application granted granted Critical
Publication of KR100404832B1 publication Critical patent/KR100404832B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/54—Spiro-condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/96—Spiro-condensed ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

본 발명은 개선된 면역조절제인 N,N-디메틸-8,8-디프로필-2-아자스피로[4,5]-데칸-2-프로판아민의 이말레산염에 관한 것이다. N,N-디메틸-8,8-디프로필-2-아자스피로[4,5]-데칸-2-프로판아민의 이말레산염(활성 성분)은 이를 제약적으로 허용가능한 통상의 담체 또는 희석제와 결합함으로써 제조되는 통상의 투여 형태로 투여될 수 있다. 본 발명의 화합물은 특히 류마티스성 관절염의 치료에 있어서 면역조절제로서 유용하다.

Description

N,N-디메틸-8,8-디프로필-2-아자스피로[4,5]-데칸-2-프로판아민 이말레산염
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (4)

  1. 화합물 N,N-디메틸-8,8-디프로필-2-아자스피로[4,5]-데칸-2-프로판아민 이말레산염.
  2. N,N-디메틸-8,8-디프로필-2-아자스피로[4,5]-데칸-2-프로판아민 이말레산염 및 제약적으로 허용가능한 담체 또는 희석제로 이루어지는 제약 조성물.
  3. 면역조절 유효량의 N,N-디메틸-8,8-디프로필-2-아자스피로[4,5]-데칸-2-프로판아민 이말레산염을 이와 같은 처리를 필요로하는 환자에게 투여하는 것으로 이루어지는 면역조절 유도 방법.
  4. 제3항에 있어서, 환자가 류마티스성 관절염 치료를 필요로하는 환자인 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019960028016A 1995-07-13 1996-07-11 N,n-디에틸-8,8-디프로필-2-아자스피로[4.5]데칸-2-프로판아민이말레산염 KR100404832B1 (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US113995P 1995-07-13 1995-07-13
US60/001,139 1995-07-13
US1606596P 1996-04-23 1996-04-23
US60/016,065 1996-04-23

Publications (2)

Publication Number Publication Date
KR970069987A true KR970069987A (ko) 1997-11-07
KR100404832B1 KR100404832B1 (ko) 2004-01-13

Family

ID=26668617

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019960028016A KR100404832B1 (ko) 1995-07-13 1996-07-11 N,n-디에틸-8,8-디프로필-2-아자스피로[4.5]데칸-2-프로판아민이말레산염

Country Status (29)

Country Link
EP (1) EP0753512B1 (ko)
JP (1) JP3949750B2 (ko)
KR (1) KR100404832B1 (ko)
CN (1) CN1067378C (ko)
AR (1) AR003452A1 (ko)
AT (1) ATE164154T1 (ko)
AU (1) AU716256B2 (ko)
BG (1) BG62359B1 (ko)
CA (1) CA2181006C (ko)
CZ (1) CZ289617B6 (ko)
DE (1) DE69600189T2 (ko)
DK (1) DK0753512T3 (ko)
EA (1) EA000037B1 (ko)
ES (1) ES2113765T3 (ko)
HK (1) HK1010052A1 (ko)
HU (1) HU226691B1 (ko)
IL (1) IL118815A (ko)
MA (1) MA23936A1 (ko)
MX (1) MX9602767A (ko)
NO (1) NO306672B1 (ko)
NZ (1) NZ286951A (ko)
PL (1) PL191019B1 (ko)
RO (1) RO117376B1 (ko)
SG (1) SG43383A1 (ko)
SK (1) SK281254B6 (ko)
TR (1) TR199600579A2 (ko)
TW (1) TW419462B (ko)
UA (1) UA42749C2 (ko)
UY (1) UY24283A1 (ko)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100473645C (zh) * 2000-08-08 2009-04-01 第一制药株式会社 双环化合物的制备方法及其中间体
US20070015780A1 (en) * 2003-03-10 2007-01-18 Picker Donald H Method of treating cancer with azaspirane compositions
CN104119321B (zh) * 2013-04-28 2017-09-08 齐鲁制药有限公司 二氢吲哚酮衍生物的二马来酸盐及其多晶型物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3211397A1 (de) * 1982-03-27 1983-11-10 Hoechst Ag, 6230 Frankfurt Spiro (4.(3+n))-2-aza-3-carbonsaeure-derivate, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung
US4430335A (en) * 1983-02-09 1984-02-07 Hoechst-Roussel Pharmaceuticals Inc. Substituted 1-azaspiro[4,5]decanes and their analgesic compositions
US4963557A (en) * 1987-09-28 1990-10-16 Smithkline Beecham Corporation Immunomodulatory azaspiranes
US4853409A (en) * 1988-04-13 1989-08-01 Pfizer Inc. 3-substituted-2-oxindole-1-carboxamides for suppressing T-cell function
CA1336090C (en) * 1988-08-31 1995-06-27 Isao Hayakawa Spiro-substituted cyclic amines of quinolone derivatives
PT100566B (pt) * 1991-06-07 1999-06-30 Smithkline Beecham Corp Azaspiranos imunomoduladores, composicoes farmaceuticas que os contem, sua preparacao e seu uso
GB9122735D0 (en) * 1991-10-25 1991-12-11 Smithkline Beecham Corp Methods
GB9217116D0 (en) * 1992-08-13 1992-09-23 Smithkline Beecham Corp Methods
US5506232A (en) * 1994-03-28 1996-04-09 Boehringer Mannheim Italia S.P.A. 6,9-bis[(2-aminoethyl)amino]benzo[g]isoquinoline-5,10-dione and its dimaleate salt

Also Published As

Publication number Publication date
CN1140710A (zh) 1997-01-22
TW419462B (en) 2001-01-21
EA000037B1 (ru) 1998-02-26
HUP9601918A2 (en) 1997-09-29
AU5945596A (en) 1997-01-23
MA23936A1 (fr) 1997-04-01
SK88696A3 (en) 1997-06-04
BG100710A (bg) 1997-03-31
CA2181006A1 (en) 1997-01-14
RO117376B1 (ro) 2002-02-28
HU9601918D0 (en) 1996-09-30
IL118815A0 (en) 1996-10-31
EA199600048A3 (ru) 1997-03-31
TR199600579A2 (tr) 1997-01-21
EP0753512A1 (en) 1997-01-15
AR003452A1 (es) 1998-08-05
UY24283A1 (es) 2001-10-25
AU716256B2 (en) 2000-02-24
NO962931D0 (no) 1996-07-12
BG62359B1 (bg) 1999-09-30
ES2113765T3 (es) 1998-05-01
PL315191A1 (en) 1997-01-20
HU226691B1 (en) 2009-06-29
PL191019B1 (pl) 2006-03-31
JP3949750B2 (ja) 2007-07-25
CN1067378C (zh) 2001-06-20
SK281254B6 (sk) 2001-01-18
NO962931L (no) 1997-01-14
MX9602767A (es) 1998-01-31
CA2181006C (en) 2007-04-03
UA42749C2 (uk) 2001-11-15
EP0753512B1 (en) 1998-03-18
DE69600189D1 (de) 1998-04-23
EA199600048A2 (ru) 1996-12-30
DE69600189T2 (de) 1998-10-15
JPH09118618A (ja) 1997-05-06
IL118815A (en) 2000-06-29
ATE164154T1 (de) 1998-04-15
KR100404832B1 (ko) 2004-01-13
HK1010052A1 (en) 1999-06-11
SG43383A1 (en) 1997-10-17
DK0753512T3 (da) 1998-10-19
NZ286951A (en) 1998-02-26
CZ203696A3 (en) 1997-03-12
NO306672B1 (no) 1999-12-06
CZ289617B6 (cs) 2002-03-13
HUP9601918A3 (en) 1998-01-28

Similar Documents

Publication Publication Date Title
ATE72448T1 (de) 2-alkynyladenosine als aktive bestandteile enthaltende antihypertensive mittel.
CA2244785A1 (en) Pentafluorobenzenesulfonamides and analogs
DE69425304D1 (de) Zyklische antimikrobielle Peptide und deren Herstellung
CA2176360A1 (en) Pharmaceutical emulsion
IL108382A0 (en) Amino acid derivatives, their preparation and pharmaceutical compositions containing them
AU5669198A (en) Cyclosporin derivative, its preparation and pharmaceutical compositions containing same
AU5669298A (en) Cyclosporin derivatives, their preparation and pharmaceutical compositions containing them
AU667593B2 (en) Inhibitors of HIV protease useful for the treatment of AIDS
BR9813214A (pt) Antagonista de receptor vitronectina
WO1993014767A3 (en) Pharmaceutical preparation based on rhamnolipid against dermatological diseases, e.g. papilloma virus infections
MD1560F2 (en) Cyclic compounds, pharmaceutical compositions on base thereof and methods of treatment of infections or diseases provoked by retroviruses.
DE69434652D1 (de) Antikonvulsive pseudofructopyranose sulfamate
KR970069987A (ko) N,n- 디에틸- 8,8- 디프로필- 2- 아자스피로[4.5]데칸- 2- 프로판아민 이말레산염
DE69917467D1 (de) Reversible borkomplexe von 1,2-(cis)-diol zyklischen peptiden
UA74388C2 (uk) Фармацевтичні композиції тизоксаніду і нітазоксаніду
TW330933B (en) Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes
NZ246598A (en) Trazodone derivatives; compounds and preparation, pharmaceutical compositions; intermediate compounds
KR970704441A (ko) 사람 면역결핍증 바이러스 프로테아제 억제제 배합물(HIV Protease inhibitor combination)
KR940021524A (ko) 1,2,5,6-테트라하이드로피리딘 유도체와 이의 제조 방법 및 치료시 이의 이용방법
MXPA98005355A (es) Derivados de 5-[(heteroaril) alquil]-3 -oxo-pirido [1, 2-a]bencimidazol -4-carboxamida utiles en el tratamiento de trastornos del sistema nervioso central.
GR3031908T3 (en) Novel 17-hydroxyiminoalkyl and 17-hydroxyiminomethylalkenyl cyclopentaneperhydrophenanthrene derivatives active on the cardiovascular system, a process for their preparation and pharmaceutical compositions containing same
FI922519A (fi) Menetelmä farmaseuttisesti käyttökelpoisten pilokarpiinijohdannaisten valmistamiseksi
GR920100423A (el) Ανταγωνιστές 5-ΗΤ4 κινολιζιδινυλ εστέρος.
UA30826A (uk) Спосіб лікування хейліту

Legal Events

Date Code Title Description
N231 Notification of change of applicant
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20091020

Year of fee payment: 7

LAPS Lapse due to unpaid annual fee